1. Review the approach to treatment of HCC patients
2. Discuss the studies and molecular mechanisms that drive the current standard of care
3. Discuss current and guture investigational therapeutics for HCC
09/28/2017 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Daniel J. Olson, M.D.